Previous 10 | Next 10 |
Anika Therapeutics, Inc. (ANIK) Q1 2020 Results Earnings Conference Call May 07, 2020, 05:00 PM ET Company Participants Sylvia Cheung - Chief Financial Officer Cheryl Blanchard - President and Chief Executive Officer Conference Call Participants Presentation Operator ...
The following slide deck was published by Anika Therapeutics, Inc. in conjunction with their 2020 Q1 earnings Read more ...
Image source: The Motley Fool. Anika Therapeutics Inc (NASDAQ: ANIK) Q1 2020 Earnings Call May 8, 2020 , 11:30 p.m. ET Operator Continue reading
Anika Therapeutics (NASDAQ: ANIK ): Q1 Non-GAAP EPS of $0.45 beats by $0.23 ; GAAP EPS of $0.24 beats by $0.32 . More news on: Anika Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Total Revenue Increases 43% Year-over-Year Continued Progress on Integration of Parcus Medical and Arthrosurface Acquisitions Withdrawing Full Year 2020 Financial Guidance Well Positioned to Manage through COVID-19 Pandemic BEDFORD, Mass., May 07, 2020 (GLOBE NEWSWIRE) -- Ani...
Anika Therapeutics ( ANIK +5.2% ) appoints Cheryl Blanchard as President and CEO, effective immediately More news on: Anika Therapeutics, Inc., Healthcare stocks news, Read more ...
Seasoned industry executive with experience leading global joint preservation and restoration businesses Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) ...
Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its first quarter 2020 financial results after the close of the market on Thursday, May 7, 2020 and hold its investor conference call on the same day, Thursday, May 7, 2020, at 5:00 p.m. ET to discuss it...
Aimed at strengthening its financial position during the uncertainties associated with the current pandemic, Anika Therapeutics (NASDAQ: ANIK ) is drawing $50M from its existing credit facility, beefing up its total liquidity to ~$140M. More news on: Anika Therapeutics, Inc., Healthcare ...
BEDFORD, Mass., April 08, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (“HA”) technology platform , today provided an u...
News, Short Squeeze, Breakout and More Instantly...
Anika Therapeutics Inc. Company Name:
ANIK Stock Symbol:
NASDAQ Market:
Anika Therapeutics Inc. Website:
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika’s proprietary hyaluronic acid (HA) regenerative portfolio Over 300 surgeries completed during the limited market release, highlighting the growing interest and commerci...
2024-07-09 17:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-29 13:30:02 ET Stephens analyst issues EQUAL-WEIGHT recommendation for ANIK on May 29, 2024 12:00PM ET. The previous analyst recommendation was Equal-Weight. ANIK was trading at $25.32 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...